HEALTH TECHNOLOGY

Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S.

Alcon | March 07, 2022

Alcon the global leader in eye care dedicated to helping people see brilliantly, announced the launch of the Clareon® family of intraocular lenses (IOLs) in the U.S. Utilizing Alcon’s most advanced IOL material, Clareon can deliver consistent visual outcomes and exceptional clarity that lasts.°,1-7 The Clareon clarity is born out of a glistening-free§ IOL material that has among the lowest levels of haze and subsurface nanoglistenings compared to leading competitor IOLs.†,*,1-3

 

We are proud to offer our latest IOL technology in the U.S. and other countries across the globe. At Alcon, we are consistently pushing the boundaries to deliver transformational innovation to cataract surgeons and their patients. Clareon is the result of robust R&D efforts at every level—inventive material science, advanced manufacturing techniques and novel delivery systems—to deliver exceptional, long-lasting clarity.”

Ian Bell, President, Global Business & Innovation, Alcon

The Clareon portfolio leverages many of the same design characteristics and optics as Alcon’s leading IOLs to help deliver the outcomes surgeons expect.8,9 Clareon offers sharp, crisp vision with a proprietary edge designed to help reduce glare and posterior capsular opacification.7 The lens’ unique and proven STABLEFORCE® Haptics provide superior axial and rotational stability.*,β,8-14 Clareon has been extensively researched, with inclusion in 30 published studies worldwide. Clareon Monofocal and Clareon Toric IOLs have already been implanted in more than one million eyes across more than 70 countries.15

Clareon IOLs are inserted using the next-generation, reusable Clareon Monarch® IV Delivery System, which provides precise and controlled implantation and that was designed specifically for the new Clareon material.15,16 Clareon Monofocal is also available in the next-generation automated, single-use delivery system, AutonoMe™.

“As one of the investigators for the Clareon pivotal trial, I was immediately impressed with the clarity of the new IOL material, delivery system and the consistent refractive outcomes,” said Dr. Samuel H. Lee, MD, Ophthalmologist, Sacramento, CA.** “Today, the clarity of Clareon persists four years later in my trial patients, with the optic performance that I expect from Alcon IOLs, as well as continued high patient satisfaction.”

Clareon Monofocal, Clareon PanOptix®, Clareon PanOptix Toric, Clareon Vivity® and Clareon Vivity Toric IOLs are now available in the U.S. Clareon PanOptix offers patients the possibility of 20/20 vision at distance (far), intermediate (at arm’s length) and near (up close), with continuous vision of 20/25 or better.¥,14,17 Clareon Vivity is a non-diffractive extended depth of focus lens with wavefront-shaping X-WAVE™ technology, delivering monofocal-quality distance with excellent intermediate and functional near vision and with a monofocal visual disturbance profile.13,18

Clareon Toric will be available in the U.S. later this year. Alcon will be rolling out the Clareon family of IOLs in international markets throughout 2022 and 2023.

There are more than 28 million cataract surgeries performed each year in the world. With the aging population and increased life expectancies, these surgeries are expected to increase 3-4% per year for the next 30 years, leading to an estimated 60 million global cataract surgeries annually by 2045.19

About Cataracts

A cataract is a cloudy area in the natural lens of the eye that affects vision. As a cataract develops, the eye's lens gradually becomes hard and cloudy, allowing less light to pass through, which makes it more difficult to see. The vast majority of cataracts result from normal aging, but radiation exposure, taking steroids, diabetes and eye trauma can accelerate their development. Cataracts are the most common age-related eye condition and the leading cause of preventable blindness.20 Cataracts are treated by removing the eye's cloudy natural lens and surgically replacing it with an IOL. More than 92% of cataract surgeries are considered successful, and patients typically can return to their normal routines within 24 hours.21

About Clareon IOLs and Delivery Systems

The family of Clareon intraocular lenses (IOLs) includes the Clareon Aspheric Hydrophobic Acrylic and Clareon Aspheric Toric IOLs, the Clareon PanOptix Trifocal Hydrophobic IOL, Clareon PanOptix Toric, Clareon Vivity Extended Vision Hydrophobic Posterior Chamber IOL and Clareon Vivity Toric IOLs. Each of these IOLs is indicated for visual correction of aphakia in adult patients following cataract surgery. In addition, the Clareon Toric IOLs are indicated to correct pre-existing corneal astigmatism at the time of cataract surgery. The Clareon PanOptix lens mitigates the effects of presbyopia by providing improved intermediate and near visual acuity while maintaining comparable distance visual acuity with a reduced need for eyeglasses, compared to a monofocal IOL. The Clareon Vivity lens mitigates the effects of presbyopia by providing an extended depth of focus. Compared to an aspheric monofocal IOL, the lens provides improved intermediate and near visual acuity while maintaining comparable distance visual acuity. All of these IOLs are intended for placement in the capsular bag. Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting any IOL in a patient with any of the conditions described in the Directions for Use that accompany each IOL. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon, informing them of possible risks and benefits associated with these IOLs. Reference the Directions for Use labelling for each IOL for a complete listing of indications, warnings and precautions.

About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 24,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. 

Spotlight

What impact is paper having on your ability to capture, access and share discrete data? With increasing competition and changing regulatory requirements, the demand for easily accessible data is higher than ever. Can you meet that challenge? Learn how faster, cleaner data gathered during registration can have a profound effect on the entire organization…

Spotlight

What impact is paper having on your ability to capture, access and share discrete data? With increasing competition and changing regulatory requirements, the demand for easily accessible data is higher than ever. Can you meet that challenge? Learn how faster, cleaner data gathered during registration can have a profound effect on the entire organization…

Related News

HEALTH TECHNOLOGY

Modern Healthcare Launches Digital Health Business & Technology To Serve The Entire Digital Health Ecosystem

Modern Healthcare | October 19, 2021

Modern Healthcare, a Crain Communications brand, is pleased to announce the launch of Digital Health Business & Technology, a digital media brand that covers the latest news, data and insights on all aspects of digital healthcare technologies, from hardware, software products and services to finance, investment and mergers and acquisitions activity. The new digital brand leverages the editorial expertise of Modern Healthcare, an industry-leading provider of healthcare business news for more than 45 years, as well as 10 years of global digital health deal information and analysis acquired from Mercom Capital's Digital Health Business in June 2021. The resulting product portfolio will include: The Digital Health Business and Technology website (DigitalHealthBusinessandTechnology.com), featuring news coverage, a research and data center and quarterly M&A reports The Digital Health Deal and Digital Health Intel weekly e-newsletters A Digital Health Alert for breaking industry news For a limited time, healthcare executives in senior leadership roles in operations, financial and clinical management, information technology and related areas; entrepreneurs and senior leaders within digital health solution provider companies; investment firms, private and institutional investors (commercial banks, mutual funds, etc.), venture capitalists; private equity firms and angel investors, are invited to register for trial access to online content and e-newsletters from Digital Health Business & Technology. "Digital Health Business & Technology offerings will serve the needs of the entire digital health ecosystem, enabling healthcare executives, entrepreneurs, business leaders and investors to determine how best to leverage digital health solutions for improved outcomes, accelerated innovation and greater business growth," said Fawn Lopez, publisher of Modern Healthcare. "Our digital health portfolio will serve the information needs of healthcare executives who are seeking to understand the strategic business value of the latest digital health technology solutions to their operations, along with technology professionals at provider and clinical organizations who evaluate and determine which technology solutions are the right fit for their digital health strategies, and investors who track deals, IPOs and M&A activity to identify trends for future investment in digital health companies." Jon Morton, general manager of Digital Health Business & Technology According to McKinsey & Company, in 2019, digital health represented a global market worth approximately $350 billion. All digital health value pools are expected to grow by at least 8% annually through 2024, leading to an estimated market size of at least $600 billion. About Modern Healthcare, published by Crain Communications Inc Modern Healthcare is the industry's leading source of healthcare business and policy news, research and information, reporting on important healthcare events and trends as they happen on the web, in newsletters and alerts, the MH print magazine and events. Modern Healthcare's unbiased approach and commitment to fair reporting provides news and information that you can trust. Delivering in depth analysis, readers rely on Modern Healthcare to provide the insight into what is happening next, how it will impact organizations and what can be done to ensure success in an ever-changing healthcare landscape.

Read More

DIGITAL HEALTHCARE

Rainbow Health Launches Technology Platform to Extend Services for Hospital-at-Home Programs

Rainbow Health | December 20, 2021

Rainbow Health today announced an extension of its platform Rainbow Care™ to encompass increased features for providers and health systems that offer hospital-at-home programs. The extended services will offer superior care coordination via Rainbow Health's platform and have been designed to address the logistical challenges that hospital-at-home programs are facing, while keeping an overall goal of supporting the operationalization and scalability of the programs. Hospital-at-home programs are experiencing tremendous growth. In April 2021, there were around 56 Health Systems operational at 127 Hospitals across 29 States; in September 2021, there were around 71 Health Systems operational at 163 Hospitals across 33 states. Rainbow Care's platform manages patient eligibility, dispatch visit scheduling, telemedicine and monitoring vital signs through RPM devices. In addition, the solution provides extended integration of ancillary services for both virtual and in-home to support new care pathways. Rainbow Health's platform has helped coordinate care in over 1400+ at-home visits in the last few months, covering over 1200+ homebound patients. Rainbow Care is continuing to grow across several markets nationwide. "Home is the heart of each patient's life, where they are the most comfortable and feel the safest. Patients should be the heart of healthcare delivery programs. Innovative programs introduced by the Centers for Medicare & Medicaid Services, such as the Acute Hospital Care at Home program, have led many health systems and hospitals to implement hospital-at-home programs and bring care into patients' homes." Shailendra Sinhasane, CEO of Rainbow Health Sinhasane added: "What sets Rainbow Health apart from other solutions in the market is our unified care coordination and unparalleled logistics services." Services include but are not limited to: Dispatching nurses, paramedic and other clinical disciplines for at-home visits: The Rainbow Care platform helps organizations in dispatching care team members for at-home visits. The bird's eye map view allows them to see real time-visibility and track the status of care teams members. The RPM feature allows any RPM vendor to connect: Rainbow Care has removed all limitations previously experienced by those looking to connect RPM vendors of their choice. Organizations can choose their own RPM vendor or from Rainbow Care's network. Durable medical equipment (DME), lab, and diagnostic orders: Rainbow Care can facilitate at-home DME, lab testing, and diagnostic orders. The platform's marketplace allows users to choose vendor partners based on the fastest ETA and/ or cost efficiency to meet each patient's needs. The results of any lab tests will be sent directly to the patient's doctors, who will continue the care plan as normal by directly conveying the results to the patient. The platform also efficiently improves collaboration in real time by reducing communication gaps that can occur when multiple care teams are involved in hospital-at-home operations. It includes at-home assessments that analyze social determinants data and suggest evidence-based interventions to caregivers and homecare services partners. "Rainbow Care looks forward to continuing innovating and bringing expanded capabilities to the market for home-based care delivery," Sinhasane says. "As CMS and related healthcare regulations are updated, we will continue to expand to meet the growing needs of hospital-at-home programs." The Rainbow Care platform is currently available to be deployed across all states and territories. For more information on the Rainbow Health's Platform or to get listed as a vendor in the marketplace, visit Rainbow Health today. About Rainbow Health Rainbow Health is a Houston-based healthcare technology company offering a suite of high-tech value-based care digital solutions that are configurable and scalable to meet the needs of hospitals and health systems, health plans, provider groups, home health agencies, and other risk-based organizations. Rainbow Health has extended its care coordination logistics platform to address patients' clinical and non-clinical needs such as prescription and meal deliveries, DME, transportation, wellness checks and preventive screenings and is conti

Read More

HEALTH TECHNOLOGY

Seed Group welcomes medical selfie pioneer Healthy.io as a new strategic partner

Healthy.io | February 16, 2022

Seed Group, a company of the Private Office of SheikhSaeed bin Ahmed Al Maktoum, has announced thatTel Aviv-based health tech company Healthy.iohas been brought on board as a new strategic partner. Aiming to bring the latest technology in healthcare to the UAE and the wider Gulf Cooperation Council, Healthy.io is making its regional debut with a base inDubai. Seed Group will help Healthy.io expand its operations in the region, reach out to the right audiences, provide access to top decision-makers in the government, and explore the demand for its services in the private-sector health community. Healthy.io, with offices inTel Aviv,BostonandLondon, will help increase access to healthcare in the region by offering its innovative, smartphone camera-powered platform for medical testing. Hisham Al Gurg, CEO of Seed Group and the Private Office of SheikhSaeed bin Ahmed Al Maktoum, said, "If there is one thing that the COVID-19 pandemic has underscored, it is the fact that healthcare needs to be taken seriously. The sector needs to find the best possible techniques with the help of technology to not only offer timely treatments but also work towards the long-term goal of creating a healthy and happy world. Companies like Healthy.io are the very ones making this possible. We are excited to start this journey with them." "We are excited to collaborate with the Seed Group on bringing our technology to the nearly one million people in the Emirates at risk of kidney and cardiovascular diseases who are currently untested, and to close healthcare gaps in theMiddle EastandNorth Africaregion." Yonatan Adiri, Founder and CEO of Healthy.io Founded in 2013, Healthy.io converts the smartphone's camera into a medical device, delivering clinical results at critical moments and synchronizing healthcare with the speed of life. The company's services include at-home urinalysis anddigitized wound care, which enable healthcare systems to close gaps in access and care while increasing patient satisfaction. The company's technology has been used by leading health systems like the UK's NHS and to date, more than a quarter million tests have been completed globally. The Seed Group is a notable force in the technology, healthcare, hospitality, and telecommunications landscapes in theMiddle East. Over the past 16 years, it has formed successful strategic alliances with leading global companies representing diverse regions to accelerate sustainable market entry and presence within the Gulf Cooperation Council countries. About Seed Group Over the past 16 years, Seed Group has formed strategic alliances with leading global companies representing diverse regions and industries. These companies have propelled their business interests and goals in theMiddle EastandNorth Africaregion through the support and strong base of regional connections of the Seed Group. The Group's goal is to create mutually beneficial partnerships with multinational organizations and to accelerate their sustainable market entry and presence within the MENA region. Seed Group has been a key point in the success of all its partners in the region, helping them reach their target customers and accelerate their businesses. The Private Office was established by SheikhSaeed bin Ahmed Al Maktoumto directly invest in or assist potential business opportunities in the region, which meet The Private Office's criteria. About Healthy.io Healthy.io transforms the smartphone camera into a medical device to deliver healthcare at the speed of life. The company's at-home urinalysis and digitized wound care services enable providers and healthcare systems to close gaps in access and care while increasing patient satisfaction. Healthy.io is a global leader in digital health and is a recipient of the CNBC 2020 Disruptor 50 Award, Fast Company's World's Most Innovative Companies 2020 Award, and the Financial Times 2020 Boldness in Business Award. The company is based inTel Avivand has offices inBostonandLondon.

Read More